The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

202115 citationsJournal Articlebronze Open Access

Authors

James T. Rosenbaum · Legacy Health

Michael H. Weisman · Cedars-Sinai Medical Center

Hedley Hamilton

Cassie Shafer · Spondylitis Association of America

Elin Aslanyan · Spondylitis Association of America

Richard A. Howard · Spondylitis Association of America

Kimberly Ogle · Oregon Health & Science University

Abstract

These data do not exclude a small increased risk of developing COVID-19 as a result of SpA, but the risk, if it exists, is low and not consistently demonstrated. The data should provide reassurance to patients and to rheumatologists about the risk that COVID-19 poses to patients with SpA.

Topics & Keywords

Spondyloarthritis Studies and Treatments Autoimmune and Inflammatory Disorders Research Rheumatoid Arthritis Research and Therapies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Rheumatology

Volume 49, Issue 2, pp. 225-229

DOI: 10.3899/jrheum.210742

Field-Weighted Citation Impact: 2.38